International Assets Investment Management LLC Lowers Stock Position in The Clorox Company $CLX

International Assets Investment Management LLC cut its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 96.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,154 shares of the company’s stock after selling 100,000 shares during the quarter. International Assets Investment Management LLC’s holdings in Clorox were worth $390,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brown Lisle Cummings Inc. lifted its holdings in Clorox by 4.3% during the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares in the last quarter. American National Bank & Trust raised its position in shares of Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the period. Savvy Advisors Inc. boosted its holdings in Clorox by 1.4% in the 2nd quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock worth $768,000 after buying an additional 91 shares during the period. Canandaigua National Bank & Trust Co. increased its stake in Clorox by 0.8% in the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after buying an additional 94 shares in the last quarter. Finally, State of Michigan Retirement System increased its stake in Clorox by 0.3% in the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after buying an additional 100 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox agreed to acquire GOJO Industries, the maker of Purell, for $2.25 billion in cash — a strategic push deeper into skin health and hygiene that management says is growth‑accretive and advances its IGNITE plan. The deal expands Clorox’s consumer and professional hygiene footprint and is the primary catalyst for today’s stock strength. Clorox Announces Acquisition of GOJO
  • Positive Sentiment: Management updated FY‑2026 EPS guidance to $5.95–$6.30, slightly above consensus, and reiterated revenue targets — a sign the company expects the combined portfolio and cost initiatives to help stabilize growth. This guidance helped reassure investors even as organic revenue pressures persist. (Company guidance release)
  • Neutral Sentiment: Deutsche Bank raised its price target on CLX to $114 (keeps a Hold rating), a small incremental positive that signals modest upside in analysts’ view but not a strong buy signal. Deutsche Bank Raises Price Target
  • Neutral Sentiment: Broad media and analyst coverage (WSJ, CNBC, MarketWatch) has amplified the deal’s reach and provided investors with deal details and management commentary — increasing attention but not resolving long‑term execution questions. WSJ: Clorox to Buy Purell-Maker
  • Negative Sentiment: Some sell‑side skepticism remains: Barclays kept an Underweight (sell) stance despite a small target tweak, and commentary from critics highlights valuation and fundamental concerns that could limit upside until integration is proven. Barclays Remains a Sell
  • Negative Sentiment: The deal is being financed with debt, increasing leverage and short‑term balance‑sheet risk; investors will watch integration execution and cost synergy realization closely — these risks are why some analysts remain cautious. WSJ: Deal Financed with Debt
  • Negative Sentiment: Critical commentary (e.g., Seeking Alpha) questions whether the acquisition meaningfully fixes Clorox’s underlying growth challenges and suggests the company still needs stronger organic execution — a narrative that could cap the stock if results don’t improve. Seeking Alpha: Adding Sanitizers, But In Need Of Getting Its Hands Dirty

Clorox Stock Performance

NYSE:CLX opened at $113.46 on Friday. The company has a market cap of $13.84 billion, a price-to-earnings ratio of 17.81, a PEG ratio of 0.57 and a beta of 0.58. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $164.22. The stock’s 50 day simple moving average is $103.80 and its two-hundred day simple moving average is $114.78. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the company earned $1.86 EPS. The company’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.63% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CLX shares. UBS Group dropped their price objective on Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Jefferies Financial Group restated a “buy” rating and issued a $152.00 price target on shares of Clorox in a research note on Tuesday, November 4th. Wall Street Zen lowered shares of Clorox from a “hold” rating to a “sell” rating in a report on Saturday. Morgan Stanley cut their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Finally, Rothschild & Co Redburn lowered their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus target price of $122.19.

Read Our Latest Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.